Literature DB >> 22362187

Absence of μ opioid receptor mRNA expression in astrocytes and microglia of rat spinal cord.

Sheng-Chin Kao1, Xiuli Zhao, Chun-Yi Lee, Fidelis E Atianjoh, Estelle B Gauda, Myron Yaster, Yuan-Xiang Tao.   

Abstract

Cumulating evidence has demonstrated that μ opioid receptor (MOR) agonists promote spinal glial activation, lead to synthesis and release of proinflammatory cytokines and chemokines, and contribute to opioid-induced hyperalgesia and development of opioid tolerance and dependence. However, whether these MOR agonists directly or indirectly act on spinal cord astrocytes and microglial cells in vivo is unclear. In the present study, by combining the techniques of in-situ hybridization of MOR mRNA with immunohistochemistry of glial fibrillary acidic protein (GFAP; an astrocyte marker) and Iba1 (a microglial marker), we examined expression and distribution of GFAP, Iba1, and MOR mRNA in the spinal cord of rats under chronic morphine tolerance conditions. Intrathecal injections of morphine twice daily for 7 days reduced morphine analgesic effect and increased both GFAP and Iba1 immunostaining densities in the spinal cord. Surprisingly, neither GFAP nor Iba1 colocalized with MOR mRNA in spinal cord cells. Our findings indicate that MOR expression is absent from spinal cord astrocytes and microglia, suggesting that these cell types are indirectly activated by MOR agonists under chronic opioid tolerance conditions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22362187      PMCID: PMC3315618          DOI: 10.1097/WNR.0b013e3283522e1b

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  21 in total

1.  Mu and delta opioid receptor-like immunoreactivity in the cervical spinal cord of the rat after dorsal rhizotomy or neonatal capsaicin: an analysis of pre- and postsynaptic receptor distributions.

Authors:  Catherine Abbadie; Marie Christine Lombard; Jean Marie Besson; Jodie A Trafton; Allan I Basbaum
Journal:  Brain Res       Date:  2002-03-15       Impact factor: 3.252

Review 2.  Mu opioid receptor regulation and opiate responsiveness.

Authors:  Kirsten M Raehal; Laura M Bohn
Journal:  AAPS J       Date:  2005-10-19       Impact factor: 4.009

3.  mu-Opioid receptor internalization-dependent and -independent mechanisms of the development of tolerance to mu-opioid receptor agonists: Comparison between etorphine and morphine.

Authors:  M Narita; M Suzuki; M Narita; K Niikura; A Nakamura; M Miyatake; Y Yajima; T Suzuki
Journal:  Neuroscience       Date:  2006-01-18       Impact factor: 3.590

4.  Combined fluorescent in situ hybridization and immunofluorescence: limiting factors and a substitution strategy for slide-mounted tissue sections.

Authors:  Benjamin Nehmé; Mélaine Henry; Didier Mouginot
Journal:  J Neurosci Methods       Date:  2011-01-27       Impact factor: 2.390

5.  Primary astroglial cultures derived from several rat brain regions differentially express mu, delta and kappa opioid receptor mRNA.

Authors:  B B Ruzicka; C A Fox; R C Thompson; F Meng; S J Watson; H Akil
Journal:  Brain Res Mol Brain Res       Date:  1995-12-28

Review 6.  Diversity and complexity of the mu opioid receptor gene: alternative pre-mRNA splicing and promoters.

Authors:  Ying-Xian Pan
Journal:  DNA Cell Biol       Date:  2005-11       Impact factor: 3.311

7.  Peripheral axonal injury results in reduced mu opioid receptor pre- and post-synaptic action in the spinal cord.

Authors:  Tatsuro Kohno; Ru-Rong Ji; Nobuko Ito; Andrew J Allchorne; Katia Befort; Laurie A Karchewski; Clifford J Woolf
Journal:  Pain       Date:  2005-09       Impact factor: 6.961

8.  Equal proportions of small and large DRG neurons express opioid receptor mRNAs.

Authors:  H Wang; M W Wessendorf
Journal:  J Comp Neurol       Date:  2001-01-22       Impact factor: 3.215

9.  Activation of p38 mitogen-activated protein kinase in spinal microglia mediates morphine antinociceptive tolerance.

Authors:  Yu Cui; Yu Chen; Jun-Li Zhi; Rui-Xian Guo; Jian-Qiang Feng; Pei-Xi Chen
Journal:  Brain Res       Date:  2006-01-03       Impact factor: 3.252

10.  Knockdown of spinal cord postsynaptic density protein-95 prevents the development of morphine tolerance in rats.

Authors:  W-J Liaw; B Zhang; F Tao; M Yaster; R A Johns; Y-X Tao
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

View more
  14 in total

Review 1.  Opioid-induced central immune signaling: implications for opioid analgesia.

Authors:  Peter M Grace; Steven F Maier; Linda R Watkins
Journal:  Headache       Date:  2015-03-31       Impact factor: 5.887

Review 2.  Physiology of Astroglia.

Authors:  Alexei Verkhratsky; Maiken Nedergaard
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

3.  Opioid receptor-triggered spinal mTORC1 activation contributes to morphine tolerance and hyperalgesia.

Authors:  Ji-Tian Xu; Jian-Yuan Zhao; Xiuli Zhao; Davinna Ligons; Vinod Tiwari; Fidelis E Atianjoh; Chun-Yi Lee; Lingli Liang; Weidong Zang; Dolores Njoku; Srinivasa N Raja; Myron Yaster; Yuan-Xiang Tao
Journal:  J Clin Invest       Date:  2014-01-02       Impact factor: 14.808

Review 4.  Opioids, gliosis and central immunomodulation.

Authors:  Salim Kadhim; John McDonald; David G Lambert
Journal:  J Anesth       Date:  2018-07-27       Impact factor: 2.078

5.  Differential expression and HIV-1 regulation of μ-opioid receptor splice variants across human central nervous system cell types.

Authors:  Seth M Dever; Ruqiang Xu; Sylvia Fitting; Pamela E Knapp; Kurt F Hauser
Journal:  J Neurovirol       Date:  2012-04-20       Impact factor: 2.643

Review 6.  Glial neuroimmune signaling in opioid reward.

Authors:  Hong Zhang; Tally M Largent-Milnes; Todd W Vanderah
Journal:  Brain Res Bull       Date:  2019-11-29       Impact factor: 4.077

7.  The role of gut-immune-brain signaling in substance use disorders.

Authors:  Kelsey E Lucerne; Drew D Kiraly
Journal:  Int Rev Neurobiol       Date:  2020-10-24       Impact factor: 4.280

8.  The spinal anti-inflammatory mechanism of motor cortex stimulation: cause of success and refractoriness in neuropathic pain?

Authors:  Guilherme D Silva; Patrícia S S Lopes; Erich T Fonoff; Rosana L Pagano
Journal:  J Neuroinflammation       Date:  2015-01-20       Impact factor: 8.322

9.  Loss of μ opioid receptor signaling in nociceptors, but not microglia, abrogates morphine tolerance without disrupting analgesia.

Authors:  Gregory Corder; Vivianne L Tawfik; Dong Wang; Elizabeth I Sypek; Sarah A Low; Jasmine R Dickinson; Chaudy Sotoudeh; J David Clark; Ben A Barres; Christopher J Bohlen; Grégory Scherrer
Journal:  Nat Med       Date:  2017-01-16       Impact factor: 53.440

10.  Chronic opioid therapy and opioid tolerance: a new hypothesis.

Authors:  Joel S Goldberg
Journal:  Pain Res Treat       Date:  2013-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.